CAMBRIDGE COGNITION HOLDINGS PLC Logo

CAMBRIDGE COGNITION HOLDINGS PLC

Develops digital solutions and a platform for CNS clinical trials to assess brain health.

COG | IL

Overview

Corporate Details

ISIN(s):
GB00B8DV9647 (+2 more)
LEI:
213800SZKDIN122EPA96
Country:
United Kingdom
Address:
TUNBRIDGE COURT, TUNBRIDGE LANE, BOTTISHAM, CB25 9TU CAMBRIDGE

Description

Cambridge Cognition Holdings PLC is a neuroscience technology company that develops and markets digital solutions to assess brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, featuring a suite of scientifically validated digital cognitive assessments. Its technologies include touchscreen tests, voice analysis, electronic questionnaires, and high-frequency testing, which can be deployed both in-clinic and remotely for decentralized trials. These tools are utilized by pharmaceutical companies, academic research institutions, and healthcare professionals to accelerate drug development and enhance the understanding and treatment of conditions affecting brain health. With over 30 years of scientific validation, its assessments are recognized for their sensitivity in detecting subtle cognitive changes across numerous therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 08:35
Change of Auditor
English 12.6 KB
2025-11-05 08:20
Board Updates
English 19.6 KB
2025-10-01 08:00
Block Listing Return
English 18.0 KB
2025-09-29 08:00
Exercise of Options and Total Voting Rights
English 13.9 KB
2025-09-26 10:59
Holding(s) in Company
English 23.9 KB
2025-09-08 08:00
Holding(s) in Company
English 22.2 KB
2025-09-05 13:04
Holding(s) in Company
English 52.9 KB
2025-09-02 18:21
Holding(s) in Company
English 54.4 KB
2025-08-28 08:01
Changes to Board and Management
English 29.4 KB
2025-08-19 11:10
Monument Therapeutics Partnership with FNIH
English 30.9 KB
2025-08-12 08:00
Launch of Speaker Identification Solution
English 26.7 KB
2025-07-31 08:00
Trading update for period ended 30 June 2025
English 22.4 KB
2025-06-27 13:27
Result of AGM
English 31.6 KB
2025-06-04 08:00
Notice of AGM
English 14.4 KB
2025-05-06 18:59
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE COGNITION HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE COGNITION HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE COGNITION HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.